Non-Hodgkin's Lymphoma: Terry Gallant

Years of Research, many doctors, one answer: Rational Therapeutics

After being diagnosed with indolent non-Hodgkin’s lymphoma, Terry was given the time to research what his future steps would entail if the cancer became aggressive.

His cancer progressed a few years later, becoming painful and symptomatic. After seeing a multitude of oncologists and specialists, Terry was glad to have researched his best option for his course of treatment: A Rational Therapeutics assay with care by its founder, Robert A. Nagourney, MD.

"I was diagnosed with indolent non-Hodgkin's lymphoma.

My disease was minimal, and I was advised against any chemotherapy unless it became problematic. I was referred to Dr. Nagourney repeatedly by several patients and medical doctors when I learned about the functional profiling assay. But, there was no reason to do an assay before treatment was needed.

The chemotherapy prescribed by Dr. Nagourney ended in March of 2003. I have enjoyed a deep, full remission ever since — now approaching seven years! This is truly remarkable for non-Hodgkin's lymphoma.

Over the next several years, I searched many cancer facilities and oncologists trying to determine where I wanted to be if and when I might need treatment. Many doctors I didn't like, and very few were at all satisfying. In these years, the cancer developed quickly and kept me in a lot of pain.  Delaying further treatment was no longer an option.

By now, I had seen twenty separate oncologists in my battle with cancer.

There was no doubt in my mind that Dr. Nagourney was the one I wanted to treat me.

He did an assay on my malignant tissue and offered to treat me any way I liked—a toxic chemotherapy toward a fast remission or slower less toxic therapies. He said whichever I chose; he knew he could succeed at getting me into a long-term remission."

How We Test Your Cancer Infographic

Currently, hundreds of drugs, drug combinations and targeted agents are used to treat cancer patients. With so many choices, how does your oncologist decide which ones are right for you?